Abstract
Gadd45a, Gadd45b, and Gadd45g have been implicated in cell cycle arrest, DNA repair, apoptosis, innate immunity, genomic stability, and modulation of normal blood cell development and leukemia. Each of the Gadd45 genes was shown to be regulated independently in myeloid cells in response to cytokine stimulation modulating blood cell survival and differentiation, including maintaining the quiescent stem cell pool. Gadd45a and Gadd45b were also shown to mediate the protective effects from UV in hematopoietic cells by separate signaling pathways involving either p38 activation or JNK inhibition. Furthermore, it was shown that gadd45a methylation in AML is predictive of poor survival. It was also shown that loss of Gadd45b accelerates the development of BCR-ABL driven CML in mice and leads to decreased median survival. The Gadd45b-deficient CML progenitors exhibited increased proliferation and decreased apoptosis, and this was associated with hyper-activation of c-Jun NH2-terminal kinase and Stat5. Moreover, loss of Gadd45a also accelerated the development of BCR-ABL driven CML, and this was associated with enhanced PI3K-AKT-mTOR-4E-BP1 signaling, upregulation of p30C/EBPα expression, and hyper-activation of p38 and Stat5. In human patients with chronic phase CML, gadd45a expression is up-regulated, whereas in accelerated and blast crisis phase patients, gadd45a is downregulated. Collectively, these results provide novel evidence that Gadd45a functions as a suppressor of BCR/ABL driven leukemia and may serve as a unique prognostic marker of CML progression. Thus Gadd45 proteins provide excellent targets for leukemia therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA (1991) Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene 6(1):165–167
Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace A, Liebermann D (2003) Cell survival and a Gadd45-factor deficiency. Nature 424(6950):741–741. https://doi.org/10.1038/424741b
Azam N, Vairapandi M, Zhang W, Hoffman B, Liebermann DA (2001) Interaction of CR6 (GADD45gamma ) with proliferating cell nuclear antigen impedes negative growth control. J Biol Chem 276(4):2766–2774. https://doi.org/10.1074/jbc.M005626200
Bennett J, Capece D, Begalli F, Verzella D, D’Andrea D, Tornatore L, Franzoso G (2018) NF-κB in the crosshairs: rethinking an old riddle. Int J Biochem Cell Biol 95:108–112. https://doi.org/10.1016/j.biocel.2017.12.020
Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT (2000) Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science (New York, NY) 287(5459):1804–1808. https://doi.org/10.1126/science.287.5459.1804
De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J et al (2001) Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414(6861):308–313. https://doi.org/10.1038/35104560
Demchenko YN, Glebov OK, Zingone A, Keats JJ, Bergsagel PL, Kuehl WM (2010) Classical and/or alternative NF-κB pathway activation in multiple myeloma. Blood 115(17):3541–3552. https://doi.org/10.1182/blood-2009-09-243535
Fan W, Richter G, Cereseto A, Beadling C, Smith KA (1999) Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18(47):6573–6582. https://doi.org/10.1038/sj.onc.1203054
Greten FR, Arkan MC, Bollrath J, Hsu L-C, Goode J, Miething C et al (2007) NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell 130(5):918–931. https://doi.org/10.1016/j.cell.2007.07.009
Gupta M, Gupta SK, Balliet AG, Hollander MC, Fornace AJ, Hoffman B, Liebermann DA (2005) Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis. Oncogene 24(48):7170–7179. https://doi.org/10.1038/sj.onc.1208847
Gupta M, Gupta SK, Hoffman B, Liebermann DA (2006a) Gadd45a and Gadd45b protect hematopoietic cells from UV-induced apoptosis via distinct signaling pathways, including p38 activation and JNK inhibition. J Biol Chem 281(26):17552–17558. https://doi.org/10.1074/jbc.M600950200
Gupta SK, Gupta M, Hoffman B, Liebermann DA (2006b) Hematopoietic cells from gadd45a-deficient and gadd45b-deficient mice exhibit impaired stress responses to acute stimulation with cytokines, myeloablation and inflammation. Oncogene 25(40):5537–5546. https://doi.org/10.1038/sj.onc.1209555
Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C et al (1999) Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97(5):575–586. https://doi.org/10.1016/s0092-8674(00)80769-2
Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L, Fornace AJ (2002) Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res 62(24):7305–7315
Hoffman B, Liebermann DA (2007) Role of gadd45 in myeloid cells in response to hematopoietic stress. Blood Cells Mol Dis 39(3):344–347. https://doi.org/10.1016/j.bcmd.2007.06.011
Hoffman B, Liebermann DA (2009) Gadd45 modulation of intrinsic and extrinsic stress responses in myeloid cells. J Cell Physiol 218(1):26–31. https://doi.org/10.1002/jcp.21582
Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R et al (1999) Genomic instability in Gadd45a-deficient mice. Nat Genet 23(2):176–184. https://doi.org/10.1038/13802
Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N et al (2005) A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 280(46):38544–38555. https://doi.org/10.1074/jbc.M504202200
Ikeda A, Shankar DB, Watanabe M, Tamanoi F, Moore TB, Sakamoto KM (2006) Molecular targets and the treatment of myeloid leukemia. Mol Genet Metab 88(3):216–224. https://doi.org/10.1016/j.ymgme.2006.03.011
Jijon H, Allard B, Jobin C (2004) NF-kappaB inducing kinase activates NF-kappaB transcriptional activity independently of IkappaB kinase gamma through a p38 MAPK-dependent RelA phosphorylation pathway. Cell Signal 16(9):1023–1032. https://doi.org/10.1016/j.cellsig.2004.02.005
Jinlian L, Yingbin Z, Chunbo W (2007) P38 MAPK in regulating cellular responses to ultraviolet radiation. J Biomed Sci 14(3):303–312. https://doi.org/10.1007/s11373-007-9148-4
Jirmanova L, Jankovic D, Fornace AJ, Ashwell JD (2007) Gadd45alpha regulates p38-dependent dendritic cell cytokine production and Th1 differentiation. J Immunol (Baltimore, Md.: 1950) 178(7):4153–4158. https://doi.org/10.4049/jimmunol.178.7.4153
Karlsson C, Akula MK, Staffas A, Cisowski J, Sayin VI, Ibrahim MX, Lindahl P, Bergo MO (2020) Knockout of the RAS endoprotease RCE1 accelerates myeloid leukemia by downregulating GADD45b. Leukemia 35(2):606–609
Kovalsky O, Lung FD, Roller PP, Fornace AJ (2001) Oligomerization of human Gadd45a protein. J Biol Chem 276(42):39330–39339. https://doi.org/10.1074/jbc.M105115200
Liebermann DA, Hoffman B (2003) Myeloid differentiation (MyD) primary response genes in hematopoiesis. Blood Cells Mol Dis 31(2):213–228
Liebermann DA, Hoffman B (2007) Gadd45 in the response of hematopoietic cells to genotoxic stress. Blood Cells Mol Dis 39(3):329–335. https://doi.org/10.1016/j.bcmd.2007.06.006
Liebermann DA, Tront JS, Sha X, Mukherjee K, Mohamed-Hadley A, Hoffman B (2011) Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog 16(1–2):129–140
Liu J, Lin A (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15(1):36–42. https://doi.org/10.1038/sj.cr.7290262
Lu B, Yu H, Chow C, Li B, Zheng W, Davis RJ, Flavell RA (2001) GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 14(5):583–590
Lu B, Ferrandino AF, Flavell RA (2004) Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells. Nat Immunol 5(1):38–44. https://doi.org/10.1038/ni1020
Maeda T, Hanna AN, Sim AB, Chua PP, Chong MT, Tron VA (2002) GADD45 regulates G2/M arrest, DNA repair, and cell death in keratinocytes following ultraviolet exposure. J Invest Dermatol 119(1):22–26. https://doi.org/10.1046/j.1523-1747.2002.01781.x
Mangan JK, Reddy EP (2005) Activation of the Jak3 pathway and myeloid differentiation. Leuk Lymphoma 46(1):21–27. https://doi.org/10.1080/10428190400005320
Marone M, Bonanno G, Rutella S, Leone G, Scambia G, Pierelli L (2002) Survival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21. Leuk Lymphoma 43(1):51–57. https://doi.org/10.1080/10428190210195
Min IM, Pietramaggiori G, Kim FS, Passegué E, Stevenson KE, Wagers AJ (2008) The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell 2(4):380–391. https://doi.org/10.1016/j.stem.2008.01.015
Miyake Z, Takekawa M, Ge Q, Saito H (2007) Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain. Mol Cell Biol 27(7):2765–2776. https://doi.org/10.1128/MCB.01435-06
Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S (1994) Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83(8):2248–2254
Mukherjee K, Sha X, Magimaidas A, Maifrede S, Skorski T, Bhatia R et al (2017) Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia. Oncotarget 8(7):10809–10821. https://doi.org/10.18632/oncotarget.14580
Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S et al (2004) Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 6(2):146–153. https://doi.org/10.1038/ncb1093
Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM (2006) FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia. Stem Cells (Dayton, Ohio) 24(5):1174–1184. https://doi.org/10.1634/stemcells.2005-0519
Parikh C, Subrahmanyam R, Ren R (2007) Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice. Cancer Res 67(15):7139–7146. https://doi.org/10.1158/0008-5472.CAN-07-0778
Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153–183. https://doi.org/10.1210/edrv.22.2.0428
Perugini M, Kok CH, Brown AL, Wilkinson CR, Salerno DG, Young SM et al (2009) Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation. Leukemia 23(4):729–738. https://doi.org/10.1038/leu.2008.349
Perugini M, Iarossi DG, Kok CH, Cummings N, Diakiw SM, Brown AL et al (2013) GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations. Leukemia 27(7):1588–1592. https://doi.org/10.1038/leu.2012.346
Platanias LC (2003) The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther 98(2):129–142
Randall TD, Weissman IL (1997) Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89(10):3596–3606
Rega C, Russo R, Focà A, Sandomenico A, Iaccarino E, Raimondo D et al (2018) Probing the interaction interface of the GADD45β/MKK7 and MKK7/DTP3 complexes by chemical cross-linking mass spectrometry. Int J Biol Macromol 114:114–123. https://doi.org/10.1016/j.ijbiomac.2018.03.090
Reimann C, Arola M, Bierings M, Karow A, van den Heuvel-Eibrink MM, Hasle H et al (2006) A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia. Leukemia 20(9):1637–1638. https://doi.org/10.1038/sj.leu.2404303
Salvador JM, Mittelstadt PR, Belova GI, Fornace AJ, Ashwell JD (2005) The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38 activation pathway. Nat Immunol 6(4):396–402. https://doi.org/10.1038/ni1176
Satoh Y, Matsumura I, Tanaka H, Harada H, Harada Y, Matsui K et al (2012) C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells. Leukemia 26(2):303–311. https://doi.org/10.1038/leu.2011.202
Selvakumaran M, Lin HK, Sjin RT, Reed JC, Liebermann DA, Hoffman B (1994) The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14(4):2352–2360. https://doi.org/10.1128/mcb.14.4.2352
Sha X, Hoffman B, Liebermann DA (2018) Loss of Gadd45b accelerates BCR-ABL-driven CML. Oncotarget 9(70):33360–33367. https://doi.org/10.18632/oncotarget.26076
Smith ML, Kontny HU, Zhan Q, Sreenath A, O’Connor PM, Fornace AJ (1996) Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene 13(10):2255–2263
Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR et al (2000) p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol 20(10):3705–3714. https://doi.org/10.1128/mcb.20.10.3705-3714.2000
Thalheimer FB, Wingert S, De Giacomo P, Haetscher N, Rehage M, Brill B et al (2014) Cytokine-regulated GADD45G induces differentiation and lineage selection in hematopoietic stem cells. Stem Cell Reports 3(1):34–43. https://doi.org/10.1016/j.stemcr.2014.05.010
Thyss R, Virolle V, Imbert V, Peyron J-F, Aberdam D, Virolle T (2005) NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death. EMBO J 24(1):128–137. https://doi.org/10.1038/sj.emboj.7600501
Tornatore L, Marasco D, Dathan N, Vitale RM, Benedetti E, Papa S et al (2008) Gadd45 beta forms a homodimeric complex that binds tightly to MKK7. J Mol Biol 378(1):97–111. https://doi.org/10.1016/j.jmb.2008.01.074
Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C et al (2014) Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors. Cancer Cell 26(4):495–508. https://doi.org/10.1016/j.ccr.2014.07.027
Tornatore L, Capece D, D’Andrea D, Begalli F, Verzella D, Bennett J et al (2019a) Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma. Br J Haematol 185(3):588–592. https://doi.org/10.1111/bjh.15569
Tornatore L, Capece D, D’Andrea D, Begalli F, Verzella D, Bennett J et al (2019b) Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3. Toxicol Rep 6:369–379. https://doi.org/10.1016/j.toxrep.2019.04.006
Tront JS, Hoffman B, Liebermann DA (2006) Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res 66(17):8448–8454. https://doi.org/10.1158/0008-5472.CAN-06-2013
Tront JS, Huang Y, Fornace AJ, Fornace AA, Hoffman B, Liebermann DA (2010) Gadd45a functions as a promoter or suppressor of breast cancer dependent on the oncogenic stress. Cancer Res 70(23):9671–9681. https://doi.org/10.1158/0008-5472.CAN-10-2177
Vairapandi M, Balliet AG, Fornace AJ, Hoffman B, Liebermann DA (1996) The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. Oncogene 12(12):2579–2594
Vairapandi M, Azam N, Balliet AG, Hoffman B, Liebermann DA (2000) Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 AND Gadd45-mediated negative growth control. J Biol Chem 275(22):16810–16819. https://doi.org/10.1074/jbc.275.22.16810
Vairapandi M, Balliet AG, Hoffman B, Liebermann DA (2002) GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J Cell Physiol 192(3):327–338. https://doi.org/10.1002/jcp.10140
Valk PJM, Verhaak RGW, Beijen MA, Erpelinck CAJ, van Waalwijk B, van Doorn-Khosrovani S, Boer JM et al (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350(16):1617–1628. https://doi.org/10.1056/NEJMoa040465
van Os R, Kamminga LM, Ausema A, Bystrykh LV, Draijer DP, van Pelt K et al (2007) A limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning. Stem Cells (Dayton, Ohio) 25(4):836–843. https://doi.org/10.1634/stemcells.2006-0631
Wan X, Hu B, Liu J, Feng X, Xiao W (2011) Zebrafish mll gene is essential for hematopoiesis. J Biol Chem 286(38):33345–33357. https://doi.org/10.1074/jbc.M111.253252
Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L et al (1999) GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A 96(7):3706–3711. https://doi.org/10.1073/pnas.96.7.3706
Wang X, Destrument A, Tournier C (2007) Physiological roles of MKK4 and MKK7: insights from animal models. Biochim Biophys Acta 1773(8):1349–1357. https://doi.org/10.1016/j.bbamcr.2006.10.016
Wingert S, Rieger MA (2016) Terminal differentiation induction as DNA damage response in hematopoietic stem cells by GADD45A. Exp Hematol 44(7):561–566. https://doi.org/10.1016/j.exphem.2016.04.006
Wingert S, Thalheimer FB, Haetscher N, Rehage M, Schroeder T, Rieger MA (2016) DNA-damage response gene GADD45A induces differentiation in hematopoietic stem cells without inhibiting cell cycle or survival. Stem Cells (Dayton, Ohio) 34(3):699–710. https://doi.org/10.1002/stem.2282
Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ et al (2003) Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem 278(44):43001–43007. https://doi.org/10.1074/jbc.M307869200
Zazzeroni F, Papa S, Algeciras-Schimnich A, Alvarez K, Melis T, Bubici C et al (2003) Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis. Blood 102(9):3270–3279. https://doi.org/10.1182/blood-2003-03-0689
Zerbini LF, Wang Y, Czibere A, Correa RG, Cho J-Y, Ijiri K et al (2004) NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci U S A 101(37):13618–13623. https://doi.org/10.1073/pnas.0402069101
Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace AJ (1999) Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18(18):2892–2900. https://doi.org/10.1038/sj.onc.1202667
Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K et al (1999) CR6: a third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 18(35):4899–4907. https://doi.org/10.1038/sj.onc.1202885
Zhang W, Hoffman B, Liebermann DA (2001) Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis. Int J Oncol 18(4):749–757
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Liebermann, D.A. (2022). Gadd45 in Normal Hematopoiesis and Leukemia. In: Zaidi, M.R., Liebermann, D.A. (eds) Gadd45 Stress Sensor Genes. Advances in Experimental Medicine and Biology, vol 1360. Springer, Cham. https://doi.org/10.1007/978-3-030-94804-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-94804-7_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94803-0
Online ISBN: 978-3-030-94804-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)